Sapient Capital LLC Y M Abs Therapeutics, Inc. Transaction History
Sapient Capital LLC
- $5.18 Billion
- Q4 2024
A detailed history of Sapient Capital LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 43,700 shares of YMAB stock, worth $263,948. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,700
Previous 43,700
-0.0%
Holding current value
$263,948
Previous $573,000
40.31%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
113Shares Held
26.9MCall Options Held
5.6KPut Options Held
900-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$25.6 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$17.7 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$17.3 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$13.3 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$12.1 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $264M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...